Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients

Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients

<p>Abstract</p> <p>Background</p> <p>In HIV-infected patients, combination antiretroviral therapy (cART) is associated with clinical lipodystrophy (CL) and metabolic abnormalities (MA). This study aimed to evaluate the prevalence of the metabolic syndrome (MS) and its c...

Full description

Bibliographic Details
Main Authors: Sarmento António, Martinez Esteban, Marques Rui, Xerinda Sandra, Santos Ana, Souto Selma, Carvalho Davide, Freitas Paula, Medina José
Format: Article
Language:English
Published: BMC 2011-09-01
Series:BMC Infectious Diseases
Subjects:
Metabolic syndrome
Cardiovascular Risk
Lipodystrophy
HIV infection
Online Access:http://www.biomedcentral.com/1471-2334/11/246

Internet

http://www.biomedcentral.com/1471-2334/11/246

Similar Items